tm
Seeing Is Believing
tm
Seeing Is Believing
BHVN is currently covered by 12 analysts with an average price target of $26.91. This is a potential upside of $15.55 (136.88%) from yesterday's end of day stock price of $11.36.
Biohaven Pharmaceutical Holding Co Ltd's activity chart (see below) currently has 91 price targets and 98 ratings on display. The stock rating distribution of BHVN is 81.25% BUY and 18.75% HOLD.
Analysts average stock forecasts to be materialized ratio is 63.72% with an average time for these price targets to be met of 124 days.
Highest price target for BHVN is $75, Lowest price target is $10, average price target is $30.1.
Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 06-Jan-2026. First documented stock forecast 12-Oct-2022.
Currently out of the existing stock ratings of BHVN, 26 are a BUY (81.25%), 6 are a HOLD (18.75%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 24-Jul-2024
$21
$9.64 (84.86%)
$26
1 months 9 days ago
(06-Jan-2026)
0/6 (0%)
$11.38 (118.30%)
Hold Since 03-Dec-2025
$11
$-0.36 (-3.17%)
$11
1 months 20 days ago
(26-Dec-2025)
3/13 (23.08%)
$-0.15 (-1.35%)
30
Hold Since 26-Nov-2025
$11
$-0.36 (-3.17%)
$26
2 months 20 days ago
(26-Nov-2025)
2/6 (33.33%)
$1.52 (16.03%)
26
Buy Since 04-Jan-2023
$15
$3.64 (32.04%)
$55
2 months 26 days ago
(20-Nov-2025)
7/12 (58.33%)
$5.37 (55.76%)
56
Buy Since 02-Dec-2022
$16
$4.64 (40.85%)
$16
2 months 28 days ago
(18-Nov-2025)
4/8 (50%)
$6.55 (69.31%)
108
What is BHVN (Biohaven Pharmaceutical Holding Co Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on BHVN (Biohaven Pharmaceutical Holding Co Ltd) with a proven track record?
Which analyst has the most public recommendations on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?
Which analyst is the currently most bullish on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?
Which analyst is the currently most reserved on BHVN (Biohaven Pharmaceutical Holding Co Ltd)?
